ArticleJournal of the American Heart Association2014

A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.

Dawn M Waterworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.